Correlation Between Humacyte and Equillium
Can any of the company-specific risk be diversified away by investing in both Humacyte and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humacyte and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Humacyte and Equillium, you can compare the effects of market volatilities on Humacyte and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humacyte with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humacyte and Equillium.
Diversification Opportunities for Humacyte and Equillium
Very weak diversification
The 3 months correlation between Humacyte and Equillium is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Humacyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humacyte are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Humacyte i.e., Humacyte and Equillium go up and down completely randomly.
Pair Corralation between Humacyte and Equillium
Assuming the 90 days horizon Humacyte is expected to generate 2.64 times more return on investment than Equillium. However, Humacyte is 2.64 times more volatile than Equillium. It trades about 0.05 of its potential returns per unit of risk. Equillium is currently generating about 0.1 per unit of risk. If you would invest 183.00 in Humacyte on October 7, 2024 and sell it today you would earn a total of 0.00 from holding Humacyte or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Humacyte vs. Equillium
Performance |
Timeline |
Humacyte |
Equillium |
Humacyte and Equillium Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Humacyte and Equillium
The main advantage of trading using opposite Humacyte and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humacyte position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.The idea behind Humacyte and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |